{"id":"https://openalex.org/W3133588053","doi":"https://doi.org/10.1016/j.jcf.2021.02.011","title":"Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study","display_name":"Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study","publication_year":2021,"publication_date":"2021-03-12","ids":{"openalex":"https://openalex.org/W3133588053","doi":"https://doi.org/10.1016/j.jcf.2021.02.011","mag":"3133588053","pmid":"https://pubmed.ncbi.nlm.nih.gov/33715994"},"language":"en","primary_location":{"id":"doi:10.1016/j.jcf.2021.02.011","doi":"https://doi.org/10.1016/j.jcf.2021.02.011","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jcf.2021.02.011","pdf_url":"http://www.cysticfibrosisjournal.com/article/S1569199321000461/pdf","source":{"id":"https://openalex.org/S147774598","display_name":"Journal of Cystic Fibrosis","issn_l":"1569-1993","issn":["1569-1993","1873-5010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cystic Fibrosis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cysticfibrosisjournal.com/article/S1569199321000461/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005915390","display_name":"Patrick A. Flume","orcid":"https://orcid.org/0000-0002-1560-6879","observed_orcids":["https://orcid.org/0000-0002-1560-6879"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Patrick A. Flume","raw_affiliation_strings":["Medical University of South Carolina, Charleston, SC, United States. Electronic address: flumepa@musc.edu","Medical University of South Carolina, Charleston, SC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of South Carolina, Charleston, SC, United States. Electronic address: flumepa@musc.edu","institution_ids":["https://openalex.org/I153297377"]},{"raw_affiliation_string":"Medical University of South Carolina, Charleston, SC, United States","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027049859","display_name":"E. Amelina","orcid":"https://orcid.org/0000-0002-5356-9415","observed_orcids":["https://orcid.org/0000-0002-5356-9415"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena Amelina","raw_affiliation_strings":["Pulmonary Research Institute, Moscow, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pulmonary Research Institute, Moscow, Russian Federation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029091133","display_name":"Cori L. Daines","orcid":"https://orcid.org/0000-0001-6447-7957","observed_orcids":["https://orcid.org/0000-0001-6447-7957"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cori L. Daines","raw_affiliation_strings":["University of Arizona Department of Pediatrics, Arizona, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona Department of Pediatrics, Arizona, United States","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113764893","display_name":"Brett Charlton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163709","display_name":"Pharmaxis (Australia)","ror":"https://ror.org/054xyc945","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210163709"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Brett Charlton","raw_affiliation_strings":["Pharmaxis Ltd, Frenchs Forest, Sydney, SA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaxis Ltd, Frenchs Forest, Sydney, SA","institution_ids":["https://openalex.org/I4210163709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004271838","display_name":"Joanna Leadbetter","orcid":"https://orcid.org/0000-0002-0607-2975","observed_orcids":["https://orcid.org/0000-0002-0607-2975"]},"institutions":[{"id":"https://openalex.org/I4210163709","display_name":"Pharmaxis (Australia)","ror":"https://ror.org/054xyc945","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210163709"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Joanna Leadbetter","raw_affiliation_strings":["Pharmaxis Ltd, Frenchs Forest, Sydney, SA"],"raw_orcid":"https://orcid.org/0000-0002-0607-2975","affiliations":[{"raw_affiliation_string":"Pharmaxis Ltd, Frenchs Forest, Sydney, SA","institution_ids":["https://openalex.org/I4210163709"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087246234","display_name":"Alessandro Guasconi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandro Guasconi","raw_affiliation_strings":["Chiesi Farmaceutici SpA, Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiesi Farmaceutici SpA, Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108626956","display_name":"Moira L. Aitken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Moira L. Aitken","raw_affiliation_strings":["University of Washington Medical Center, Seattle, Washington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington Medical Center, Seattle, Washington, United States","institution_ids":["https://openalex.org/I2801852214"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5005915390"],"corresponding_institution_ids":["https://openalex.org/I153297377"],"apc_list":{"value":3700,"currency":"USD","value_usd":3700},"apc_paid":{"value":3700,"currency":"USD","value_usd":3700},"fwci":1.7831,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.84846989,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"20","issue":"6","first_page":"1003","last_page":"1009"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mannitol","display_name":"mannitol","score":0.9139999747276306},{"id":"https://openalex.org/keywords/dry-powder-inhaler","display_name":"dry powder inhaler","score":0.9259999990463257},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.6480000019073486},{"id":"https://openalex.org/keywords/fev1","display_name":"FEV1","score":0.9850000143051147},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.4129999876022339},{"id":"https://openalex.org/keywords/adults","display_name":"adults","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9181326627731323},{"id":"https://openalex.org/C2778445172","wikidata":"https://www.wikidata.org/wiki/Q407646","display_name":"Mannitol","level":2,"score":0.7619611024856567},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.7332965135574341},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5995252132415771},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5899085402488708},{"id":"https://openalex.org/C2780261241","wikidata":"https://www.wikidata.org/wiki/Q1394363","display_name":"Inhaler","level":3,"score":0.5685423612594604},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5401237607002258},{"id":"https://openalex.org/C2777419714","wikidata":"https://www.wikidata.org/wiki/Q1334805","display_name":"Dry-powder inhaler","level":4,"score":0.5393500328063965},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.442852258682251},{"id":"https://openalex.org/C75603125","wikidata":"https://www.wikidata.org/wiki/Q1877462","display_name":"Pulmonary function testing","level":2,"score":0.422102153301239},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3890744745731354},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34553733468055725},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.20968231558799744},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005541","descriptor_name":"Forced Expiratory Volume","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008353","descriptor_name":"Mannitol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D058995","descriptor_name":"Dry Powder Inhalers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jcf.2021.02.011","doi":"https://doi.org/10.1016/j.jcf.2021.02.011","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jcf.2021.02.011","pdf_url":"http://www.cysticfibrosisjournal.com/article/S1569199321000461/pdf","source":{"id":"https://openalex.org/S147774598","display_name":"Journal of Cystic Fibrosis","issn_l":"1569-1993","issn":["1569-1993","1873-5010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cystic Fibrosis","raw_type":"journal-article"},{"id":"pmid:33715994","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33715994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.jcf.2021.02.011","doi":"https://doi.org/10.1016/j.jcf.2021.02.011","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jcf.2021.02.011","pdf_url":"http://www.cysticfibrosisjournal.com/article/S1569199321000461/pdf","source":{"id":"https://openalex.org/S147774598","display_name":"Journal of Cystic Fibrosis","issn_l":"1569-1993","issn":["1569-1993","1873-5010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cystic Fibrosis","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309888","display_name":"Chiesi Farmaceutici","ror":"https://ror.org/0511bn634"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3133588053.pdf","grobid_xml":"https://content.openalex.org/works/W3133588053.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1607065932","https://openalex.org/W1976264709","https://openalex.org/W2018417584","https://openalex.org/W2040975079","https://openalex.org/W2047080603","https://openalex.org/W2047582511","https://openalex.org/W2048129161","https://openalex.org/W2079925652","https://openalex.org/W2096013141","https://openalex.org/W2104379296","https://openalex.org/W2108676410","https://openalex.org/W2124135806","https://openalex.org/W2124798883","https://openalex.org/W2131236190","https://openalex.org/W2134260485","https://openalex.org/W2144947606","https://openalex.org/W2145454135","https://openalex.org/W2146890489","https://openalex.org/W2152715766","https://openalex.org/W2166059037","https://openalex.org/W2168454304","https://openalex.org/W2253808859","https://openalex.org/W2333398204","https://openalex.org/W2604428838","https://openalex.org/W2782069977","https://openalex.org/W2906834688","https://openalex.org/W2947745877","https://openalex.org/W4211009199","https://openalex.org/W4232966707"],"related_works":["https://openalex.org/W2104379296","https://openalex.org/W2124798883","https://openalex.org/W2592166454","https://openalex.org/W2001492346","https://openalex.org/W2807790643","https://openalex.org/W1932703961","https://openalex.org/W2132665778","https://openalex.org/W2047080603","https://openalex.org/W2020736221","https://openalex.org/W2047582511"],"abstract_inverted_index":{"Background":[0],":":[1,44,101,227],"Mannitol":[2,263],"is":[3],"a":[4,22,123,238,265],"mucoactive":[5],"hyperosmotic":[6],"agent":[7],"used":[8],"as":[9,237],"add-on":[10],"therapy":[11],"in":[12,41,64,127,174,184,206,212],"patients":[13],"with":[14,58,122,208,230,249,251],"cystic":[15],"fibrosis":[16],"(CF),":[17],"administered":[18],"twice-daily":[19],"(BID)":[20],"via":[21,84],"small,":[23],"portable,":[24],"breath-actuated":[25],"dry-powder":[26,85,239],"inhaler.":[27],"This":[28,45,160],"study":[29],"was":[30,142,161],"conducted":[31],"to":[32,145],"provide":[33],"confirmatory":[34],"evidence":[35],"of":[36,166,216],"mannitol's":[37],"efficacy":[38],"and":[39,60,170,214,223,258,269],"safety":[40,268],"adults.":[42],"Methods":[43],"multicenter,":[46],"double-blind,":[47],"randomized,":[48],"parallel-group,":[49],"controlled":[50],"clinical":[51],"trial":[52],"recruited":[53],"adults":[54,229],"(aged":[55],"\u226518":[56],"years)":[57],"CF,":[59,231],"forced":[61],"expiratory":[62],"volume":[63],"1":[65,68,93,133,188,246],"second":[66],"(FEV":[67,245],")":[69,247],"40\u201390%":[70],"predicted.":[71],"Subjects":[72],"received":[73],"either":[74],"mannitol":[75,79,110,138,219,232],"400":[76,111,139,220,233],"mg":[77,81,112,140,221,234],"or":[78,107,114,204],"50":[80],"(control),":[82],"BID":[83,113,141,222,235],"inhaler":[86],"for":[87],"26":[88,136,191],"weeks.":[89],"Primary":[90],"endpoint:":[91],"FEV":[92,132,187],"averaged":[94,134,189],"over":[95,135,190],"the":[96,120,128,167],"26-week":[97],"treatment":[98],"period.":[99],"Results":[100],"Of":[102],"423":[103],"subjects":[104,217],"randomized":[105],"(209":[106],"214":[108],"receiving":[109,218],"control,":[115,224,250],"respectively),":[116],"373":[117],"(88.2%)":[118],"completed":[119],"study,":[121],"similar":[124],"proportion":[125],"completing":[126],"two":[129],"groups.":[130],"For":[131],"weeks,":[137],"statistically":[143,240],"superior":[144],"control":[146],"(adjusted":[147],"mean":[148,182],"difference":[149,183],"54":[150],"mL":[151],"[95%":[152],"CI":[153],"8,":[154],"100":[155],"mL];":[156],"p":[157,196],"=":[158,197],"0.020).":[159],"supported":[162,254],"by":[163,171,255],"sensitivity":[164,256],"analyses":[165,257],"primary":[168],"endpoint,":[169],"observed":[172],"improvements":[173],"secondary":[175,259],"pulmonary":[176,260],"function":[177,244,261],"endpoints":[178],"(eg,":[179],"absolute":[180],"adjusted":[181],"percent":[185],"predicted":[186],"weeks":[192],"1.21%":[193],"[0.07%,":[194],"2.36%];":[195],"0.037).":[198],"Adverse":[199],"events":[200,211],"were":[201],"mainly":[202],"mild":[203],"moderate":[205],"severity,":[207],"treatment-related":[209],"adverse":[210],"15.5":[213],"12.2%":[215],"respectively.":[225],"Conclusions":[226],"In":[228],"inhaled":[236],"significantly":[241],"improved":[242],"lung":[243],"compared":[248],"this":[252],"improvement":[253],"endpoints.":[262],"had":[264],"good":[266],"overall":[267],"tolerability":[270],"profile.":[271],"ClinicalTrials.gov:":[272],"NCT02134353.":[273]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-03-15T00:00:00"}